89 related articles for article (PubMed ID: 17303779)
1. Genetic etiology of isolated low HDL syndrome: incidence and heterogeneity of efflux defects.
Kiss RS; Kavaslar N; Okuhira K; Freeman MW; Walter S; Milne RW; McPherson R; Marcel YL
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1139-45. PubMed ID: 17303779
[TBL] [Abstract][Full Text] [Related]
2. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI
Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL.
Yvan-Charvet L; Matsuura F; Wang N; Bamberger MJ; Nguyen T; Rinninger F; Jiang XC; Shear CL; Tall AR
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1132-8. PubMed ID: 17322101
[TBL] [Abstract][Full Text] [Related]
5. Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiency.
Chroni A; Duka A; Kan HY; Liu T; Zannis VI
Biochemistry; 2005 Nov; 44(43):14353-66. PubMed ID: 16245952
[TBL] [Abstract][Full Text] [Related]
6. HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles.
Mäkelä SM; Jauhiainen M; Ala-Korpela M; Metso J; Lehto TM; Savolainen MJ; Hannuksela ML
Alcohol Clin Exp Res; 2008 Jun; 32(6):991-1000. PubMed ID: 18498551
[TBL] [Abstract][Full Text] [Related]
7. Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels.
Villard EF; EI Khoury P; Frisdal E; Bruckert E; Clement K; Bonnefont-Rousselot D; Bittar R; Le Goff W; Guerin M
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):822-8. PubMed ID: 23372063
[TBL] [Abstract][Full Text] [Related]
8. The genetics of high-density lipoprotein metabolism: clinical relevance for therapeutic approaches.
Strang AC; Hovingh GK; Stroes ES; Kastelein JJ
Am J Cardiol; 2009 Nov; 104(10 Suppl):22E-31E. PubMed ID: 19895941
[TBL] [Abstract][Full Text] [Related]
9. CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects.
Gille A; Easton R; D'Andrea D; Wright SD; Shear CL
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2106-14. PubMed ID: 24969776
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles.
Vikstedt R; Metso J; Hakala J; Olkkonen VM; Ehnholm C; Jauhiainen M
Biochemistry; 2007 Oct; 46(42):11979-86. PubMed ID: 17900150
[TBL] [Abstract][Full Text] [Related]
11. Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.
He Y; Pavanello C; Hutchins PM; Tang C; Pourmousa M; Vaisar T; Song HD; Pastor RW; Remaley AT; Goldberg IJ; Costacou T; Sean Davidson W; Bornfeldt KE; Calabresi L; Segrest JP; Heinecke JW
Circulation; 2024 Mar; 149(10):774-787. PubMed ID: 38018436
[TBL] [Abstract][Full Text] [Related]
12. HDL metabolic activities in a boy with lipoprotein lipase deficiency and his family.
Brites F; Verona J; Fernández K; Henriksen F; Fruchart J; Cesar M; Castro G; Wikinski R
Eur J Clin Invest; 2004 Jul; 34(7):467-74. PubMed ID: 15255783
[TBL] [Abstract][Full Text] [Related]
13. Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant.
Gomaraschi M; Baldassarre D; Amato M; Eligini S; Conca P; Sirtori CR; Franceschini G; Calabresi L
Circulation; 2007 Nov; 116(19):2165-72. PubMed ID: 17967773
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT.
Tietjen I; Hovingh GK; Singaraja R; Radomski C; McEwen J; Chan E; Mattice M; Legendre A; Kastelein JJ; Hayden MR
Biochim Biophys Acta; 2012 Mar; 1821(3):416-24. PubMed ID: 21875686
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1.
Abdel-Razek O; Sadananda SN; Li X; Cermakova L; Frohlich J; Brunham LR
J Clin Lipidol; 2018; 12(1):116-121. PubMed ID: 29150341
[TBL] [Abstract][Full Text] [Related]
16. Elevated HDL cholesterol is functionally ineffective in cardiac transplant recipients: evidence for impaired reverse cholesterol transport.
Sviridov D; Chin-Dusting J; Nestel P; Kingwell B; Hoang A; Olchawa B; Starr J; Dart A
Transplantation; 2006 Feb; 81(3):361-6. PubMed ID: 16477221
[TBL] [Abstract][Full Text] [Related]
17. [Low concentrations of high-density lipoproteins (HDL) in plasma and coronary artery disease].
Pérez-Méndez O; Luc G; Posadas-Romero C
Arch Inst Cardiol Mex; 2000; 70(3):312-21. PubMed ID: 10959461
[No Abstract] [Full Text] [Related]
18. Identification of a novel human cellular HDL biosynthesis defect.
Rashid S; Marcil M; Ruel I; Genest J
Eur Heart J; 2009 Sep; 30(18):2204-12. PubMed ID: 19553242
[TBL] [Abstract][Full Text] [Related]
19. Gene-drug interaction: additive influence of mutant APOA1 and testosterone on plasma HDL-cholesterol.
Keyhan G; Rosset J; Wang J; Miller D; McManus R; Hegele RA
Clin Biochem; 2002 Jul; 35(5):341-6. PubMed ID: 12270762
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
